Lecture at the Japan Bioindustry Association on the search for candidate drugs for COVID-19 using AI
On Monday, July 2020, 7, Mari Yamamoto, a director of the Company and general manager of the Life Science AI Business Division, announced that "A AI system for drug discovery support against coronavirus"Cascade EyeWe gave a lecture at the Japan Bioindustry Association under the theme of "COVID-19 Candidate Therapeutic Drug Search Project".
This lecture will be given by FRONTEO's "COMBAT COVID-19This was made possible by the fact that the Japan Bioindustry Association saw the activities and related news and became interested in the drug discovery approach using AI.In the question and answer session on the day, we received questions not only about the possibility of AI drug discovery, but also about the possibility of AI in legal and fraud investigations developed in other departments of our company. I received many questions about solving problems with AI, such as "Is there sex?"It was conveyed that we had high expectations, and we felt that we were tightened.
Regarding FRONTEO's AI-based drug discovery approach, we have received inquiries from various public and private organizations from the beginning of the announcement. AI is not the only technology that gives an answer, but it can suggest possibilities and support people's work and thoughts. FRONTEO will continue to contribute to solving social issues with AI.
Click here for inquiries about "COMBAT COVID-19" and drug discovery support AI
FRONTEO Life Science AI Inquiries
Articles in the same category
Developed a new AI algorithm to be installed in the AI review tool "KIBIT Automator"
[December 12th 9st Fraud Countermeasures Study Group] Issues and Improvements in Compliance Programs for Japanese Companies Based on the Latest Policies of the U.S. Department of Justice
[December 12th webinar] Reduce the labor and cost of daily report monitoring!Introduction of automatic document sorting system "Mekiki"
[December 12st Webinar] How to Enforce Judgments in Other Countries in the United States
[December 12th Webinar] Initial Response to Corporate Scandals - 15 Skills Required of Legal and Compliance Officers -
[11/28/11/29 FRONTEO Life Science AI Business Academy] Medical DX starts in earnest Anticipating the pharmaceutical business in the age of AI and big data
[11/17 Webinar] U.S. Jurisdiction: A Guide to Doing Business in the U.S., Selling to U.S. Customers, and/or Contracting with U.S. Companies
[11/24 Webinar] Cross-border M&A practical point lecture by Japanese companies
[Held on November 11nd!22th Study Group on Economic Security] Japanese companies' BCP responses to Taiwan emergencies
Commonly viewed articles
Chugai Pharmaceutical Co., Ltd. has been posted as an introductory user.
FRONTEO's finance in NHK Close-up Gendai + "How to protect your assets? -Prescription for the ultra-low interest rate era-" broadcast on 10/30 ...
Comprehensive support for marriage activities using artificial intelligence KIBIT at the NHK special "Artificial Intelligence Angel or Devil 9" broadcast on 15/2018 ...
FRONTEO has been entrusted with an empirical research project utilizing artificial intelligence in the 30 JPO open call for participants project, following last year.
